AIA Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.56M Sell
7,742
-12,435
-62% -$4.23M 0.04% 206
2025
Q4
$8.02M Sell
20,177
-13,136
-39% -$5.81M 0.12% 115
2025
Q3
$15.2M Buy
33,313
+3,081
+10% +$1.25M 0.27% 59
2025
Q2
$9.86M Buy
30,232
+3,741
+14% +$1.04M 0.21% 60
2025
Q1
$7.15M Buy
26,491
+3,643
+16% +$936K 0.18% 68
2024
Q4
$5.38M Sell
22,848
-5,369
-19% -$1.41M 0.13% 77
2024
Q3
$7.76M Buy
28,217
+8,789
+45% +$2.29M 0.2% 58
2024
Q2
$4.72M Buy
19,428
+4,784
+33% +$755K 0.14% 81
2024
Q1
$2.19M Hold
14,644
0.07% 129
2023
Q4
$2.8M Hold
14,644
0.12% 87
2023
Q3
$2.59M Buy
14,644
+2,050
+16% +$391K 0.13% 85
2023
Q2
$2.39M Buy
12,594
+6,910
+122% +$1.37M 0.12% 86
2023
Q1
$1.14M Buy
5,684
+685
+14% +$144K 0.06% 139
2022
Q4
$1.19M Buy
4,999
+1,075
+27% +$229K 0.07% 117
2022
Q3
$785K Buy
3,924
+1,039
+36% +$198K 0.05% 151
2022
Q2
$421K Buy
+2,885
New +$409K 0.02% 257

Other funds holding ALNY